Centre Georges François Leclerc
In research, Centre Georges François Leclerc stands highest in Medicine (#5,292 of 10,443 worldwide) and Health Sciences (#7,006 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 17.3× its share of world research.
- World rank, 2022–2025
- #7,382 of 28,054 · #8,167 all time
- Rank in France
- #211 of 1,422
- Research works
- 1.1k ▲ 11% vs 2013–17
- Citations
- 23k 21.8 per fractional work
- Top-10% rate
- 14.9% record average 16.5%
- Open access
- 26% world 28%
What is Centre Georges François Leclerc known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,292 of 10,443 | 13.3% | 116 | #3655 | |
| Health SciencesDomain | #7,006 of 11,982 | 13.3% | 117 | #5044 |
Each strip is that field’s whole ranked pool, with the notch where Centre Georges François Leclerc sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Centre Georges François Leclerc specialise in?
Where its research is concentrated relative to its size: Oncology takes 17.3× the share of its output that it takes of world research.
- OncologySubfield · 34.4 works17×
- Pulmonary and Respiratory MedicineSubfield · 21.5 works7.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.6×. Every wedge is a field page.
- Immunology and Microbiology 5.6×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Arts and Humanities 1.2×
- Physics and Astronomy 0.9×
- Psychology 0.4×
- Dentistry 0.4×
- Veterinary 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Nursing 0.2×
- Economics, Econometrics and Finance 0.2×
- Earth and Planetary Sciences 0.2×
- Neuroscience 0.2×
- Chemistry 0.1×
- Computer Science 0.1×
- Health Professions 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Decision Sciences 0.1×
- Agricultural and Biological Sciences 0.0×
- Mathematics 0.0×
- Environmental Science 0.0×
Who are the top researchers at Centre Georges François Leclerc?
Ranked on the composite score, P. Fumoleau, Sylvain Ladoire and Laurent Arnould lead among researchers whose main affiliation is Centre Georges François Leclerc.
- 1 P. Fumoleau France · #14,509 worldwide 627 citations · 88 works
- 2 Sylvain Ladoire France · #24,520 worldwide 459 citations · 57 works
- 3 Laurent Arnould France · #31,478 worldwide 474 citations · 63 works
- 4 Jean-Claude Horiot France · #63,597 worldwide 200 citations · 31 works
- 5 Nicolás Isambert France · #76,385 worldwide 338 citations · 73 works
- 6 Françoise Collin France · #115,345 worldwide 65 citations · 80 works
- 7 François Ghiringhelli France · #145,461 worldwide 459 citations · 111 works
- 8 Valentin Dérangère France · #160,078 worldwide 147 citations · 30 works
- 9 Bruno Coudert France · #181,850 worldwide 296 citations · 72 works
- 10 Séverine Guiu France · #235,867 worldwide 121 citations · 27 works
Which keywords describe research at Centre Georges François Leclerc?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Radiotherapy, Breast Cancer, Tumor Microenvironment, Clinical Practice Guidelines, Cancer and Survival Analysis.
- Texture Analysis
- Breast Reconstruction
- Dosimetry
- Radiation Therapy
- Genomic Profiling
- Cetuximab
- Cancer Immunotherapy
- Genetic Mutations
- Immunity
- Metastasis
- Biomarkers
- Prognostic Factors
- Targeted Therapy
- Immune Checkpoint Blockade
- Quality of Life
- Molecular Subtypes
- Survival Analysis
- Tumor Microenvironment
- Breast Cancer
- Immunotherapy
- Chemotherapy
- Radiotherapy
- Cancer
- Clinical Practice Guidelines
- Precision Medicine
- Neoadjuvant Therapy
- Clinical Trials
- PD-1 and PD-L1
- Gene Expression
- Prognostic Markers
- Breast Tumours
- Treatment Response
- Metastatic Breast Cancer
- Molecular Characterization
- Cancer Risk
- Innate Immunity
- Ovarian Cancer
- Biopsy
- Genetic Testing
- Survival
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy21▲ 17×21 topics
- Immunotherapy15▲ 12×16 topics
- Radiotherapy14▲ 21×12 topics
- Breast Cancer14▲ 33×10 topics
- Cancer14▲ 5.7×36 topics
- Tumor Microenvironment12▲ 16×8 topics
- Clinical Practice Guidelines12▲ 13×11 topics
- Survival Analysis11▲ 23×6 topics
- Precision Medicine10▲ 12×5 topics
- Molecular Subtypes10▲ 64×3 topics
- Neoadjuvant Therapy9▲ 22×5 topics
- Quality of Life9▲ 3.5×14 topics
- Clinical Trials8▲ 7.2×8 topics
- Immune Checkpoint Blockade8▲ 42×1 topic
- PD-1 and PD-L18▲ 42×1 topic
- Targeted Therapy8▲ 20×5 topics
- Gene Expression7▲ 6.8×10 topics
- Prognostic Factors7▲ 9.6×14 topics
- Prognostic Markers7▲ 36×3 topics
- Biomarkers6▲ 5.3×12 topics
- Breast Tumours6▲ 71×1 topic
- Metastasis6▲ 9.7×12 topics
- Treatment Response6▲ 71×1 topic
- Immunity6▲ 8.0×7 topics
- Metastatic Breast Cancer6▲ 57×2 topics
- Genetic Mutations6▲ 7.3×13 topics
- Molecular Characterization5▲ 16×5 topics
- Cancer Immunotherapy5▲ 19×3 topics
- Cancer Risk5▲ 12×4 topics
- Cetuximab4▲ 31×2 topics
- Innate Immunity4▲ 7.7×8 topics
- Genomic Profiling4▲ 24×2 topics
- Ovarian Cancer4▲ 27×3 topics
- Radiation Therapy4▲ 19×5 topics
- Biopsy4▲ 39×2 topics
- Dosimetry4▲ 34×2 topics
- Genetic Testing4▲ 21×2 topics
- Breast Reconstruction4▲ 39×2 topics
- Survival4▲ 17×4 topics
- Texture Analysis4▲ 10×2 topics
Which research topics does Centre Georges François Leclerc publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Radiomics and Machine Learning in Medical Imaging and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 2 Breast Cancer Treatment Studies Cancer Research 6 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 4 Colorectal Cancer Treatments and Studies Oncology 4 works
- 5 Immunotherapy and Immune Responses Immunology 3 works
- 6 Advanced Radiotherapy Techniques Radiation 3 works
- 7 Cancer Genomics and Diagnostics Cancer Research 3 works
- 8 Cancer Treatment and Pharmacology Oncology 3 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 10 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centre Georges François Leclerc's research output changed?
Output in 2018–2022 was 11% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dijon
- Université de Bourgogne
- CHU Dijon Bourgogne
- Agroécologie
- École Nationale des Greffes
- Maison des Sciences sociales et des Humanités de Dijon
- Institut Agro Dijon
- Laboratoire d’Électronique, Informatique et Image
- Archéologie, Terre, Histoire, Sociétés
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.